MORRISVILLE, N.C.--(BUSINESS WIRE)--Cirrus Pharmaceuticals, a Kemwell company, which is a 100% services oriented company providing pharmaceutical contract development and manufacturing services, announced that it will be investing in a flexible cGMP suite in its facility in RTP, North Carolina.
Ninad Deshpanday, President of R&D at Kemwell said, “With this investment, we are bringing our customers a new service from our US facility. We will offer our clients cGMP manufacturing services for many dosage forms including inhalation, liquids, topicals and oral solids. This service will enable our clients to enter clinic faster. We have completed the design phase and expect the suite to be ready to service customers by April 2015.”
Help employers find you! Check out all the jobs and post your resume.
